Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Jul 8;9(1):240–253. doi: 10.1038/mi.2015.56

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2016 Society for Mucosal Immunology

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/

PMC Copyright notice

IL-13 does not suppress IL-17 or bleomycin-induced pathology. Representative photomicrograph of Picro-Sirius red staining of lungs from IL-17 +/− IL-13 and bleomycin (BLM) +/− IL-13-treated mice is shown (a, e). The expression of Timp1 (b), Mmp12 (c, f) was assessed in IL-17 +/− IL-13− or BLM +/− IL-13-treated mice by qPCR analysis and normalized to the house keeping gene hypoxanthine-guanine phosphoribosyltransferase (Hprt). (d) Soluble collagen lung content is shown; n=3, *P<0.05, **P<0.01, ***P<0.001. IL, interleukin.